Penumbra, Inc. (PEN)
NYSE: PEN · Real-Time Price · USD
299.78
+1.53 (0.51%)
Apr 25, 2025, 4:00 PM EDT - Market closed
Penumbra Market Cap
Penumbra has a market cap or net worth of $11.61 billion as of April 28, 2025. Its market cap has increased by 35.66% in one year.
Market Cap
11.61B
Enterprise Value
11.45B
1-Year Change
35.66%
Ranking
Category
Stock Price
$299.78
Market Cap Chart
Since September 18, 2015, Penumbra's market cap has increased from $1.23B to $11.61B, an increase of 842.08%. That is a compound annual growth rate of 26.29%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 25, 2025 | 11.61B | 27.37% |
| Dec 31, 2024 | 9.11B | -6.12% |
| Dec 29, 2023 | 9.71B | 14.91% |
| Dec 30, 2022 | 8.45B | -21.29% |
| Dec 31, 2021 | 10.73B | 68.92% |
| Dec 31, 2020 | 6.35B | 10.79% |
| Dec 31, 2019 | 5.74B | 36.03% |
| Dec 31, 2018 | 4.22B | 32.02% |
| Dec 29, 2017 | 3.19B | 58.19% |
| Dec 30, 2016 | 2.02B | 25.52% |
| Dec 31, 2015 | 1.61B | 30.52% |
View and export this data all the way back to 2015.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 794.31B |
| UnitedHealth Group | 381.06B |
| Johnson & Johnson | 371.93B |
| AbbVie | 329.14B |
| Novo Nordisk | 272.76B |
| Abbott Laboratories | 223.47B |
| AstraZeneca | 214.65B |
| Novartis AG | 211.71B |